Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Debt Ratio (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Debt Ratio readings, the most recent being 171.04 for Q1 2026.

  • On a quarterly basis, Debt Ratio rose 688.95% to 171.04 in Q1 2026 year-over-year; TTM through Feb 2026 was 171.04, a 688.95% increase, with the full-year FY2025 number at 8.28, up 89.9% from a year prior.
  • Debt Ratio reached 171.04 in Q1 2026 per CBIH's latest filing, up from 11.93 in the prior quarter.
  • The five-year high for Debt Ratio was 171.04 in Q1 2026, with the low at 2.57 in Q4 2023.
  • A 4-year average of 23.18 and a median of 7.6 in 2024 define the central range for Debt Ratio.
  • Year-over-year, Debt Ratio dropped 28.34% in 2024 and then soared 694.13% in 2025.
  • Year by year, Debt Ratio stood at 2.57 in 2023, then surged by 195.75% to 7.6 in 2024, then surged by 57.09% to 11.93 in 2025, then soared by 1333.35% to 171.04 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Debt Ratio are 171.04 (Q1 2026), 11.93 (Q4 2025), and 13.17 (Q3 2025).